Essilorluxottica shares add more after US approval

Most recently, the value in Paris won 2.18 percent to 271.80 euros and was one of the strongest titles in EuroStoxx 50. The share has increased by around 17 percent since the beginning of July.

The course received new impulses by reporting the optic group from the late evening before. After that, the company has received the only approval of the US health authority FDA for the so-called “Stellest” glasses, which brake the progress of short-sightedness in children. According to essilorluxottica, clinical studies have shown on average in 71 percent of the cases a slower progression in the period of two years.

According to RBC analyst Piral Dadhania, approval was given a little earlier than was expected. In the medium term, myopia could prove to be an important growth segment for essilorluxottica, added analyst Veronika Dubajova from Citibank. The US approval is therefore an important milestone for the company.

/MF/e.g.

——————–

dpa-Afx broker-the trader news from dpa-AfX

——————–

——————–

dpa-Afx broker-the trader news from dpa-AfX

——————–

Paris (dpa-Afx broker)

Selected leverage products on Essilorluxottica

With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the desired lever and we will show you suitable open-end products on Essilorluxottica

The lever must be between 2 and 20

Advertising